Pasatru’s FDA Approval Puts Regeneron’s Rare-Disease Playbook To The Test
Pasatru’s FDA Approval Puts Regeneron’s Rare-Disease Playbook To The Test insights.citeline.com
August 2026
FDA Approves Garetosmab-grts, First Treatment for FOP Bone Growth
FDA Approves Garetosmab-grts, First Treatment for FOP Bone Growth Pharmacy Times
FDA Approves Garetosmab for Adults With Fibrodysplasia Ossificans Progressiva
FDA Approves Garetosmab for Adults With Fibrodysplasia Ossificans Progressiva Patient Care Online
Regeneron drug for disease that causes dangerous bone growth earns FDA approval
Regeneron drug for disease that causes dangerous bone growth earns FDA approval STAT
US FDA approves Regeneron’s rare bone disorder drug
US FDA approves Regeneron's rare bone disorder drug Reuters